Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
(NY:
ALUR
)
1.960
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ALUR
< Previous
1
2
Next >
Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey
May 02, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Preliminary First Quarter 2024 Results
April 30, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
12 Consumer Discretionary Stocks Moving In Friday's Intraday Session
April 19, 2024
Via
Benzinga
Why Is Allurion (ALUR) Stock Up 65% Today?
April 04, 2024
With Allurion launching its weight-loss management suite, ALUR stock skyrocketed amid popularity for the underlying treatment approach.
Via
InvestorPlace
Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments
April 17, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
April 16, 2024
Via
Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session
April 10, 2024
Via
Benzinga
12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session
April 08, 2024
Via
Benzinga
12 Consumer Discretionary Stocks Moving In Friday's Intraday Session
April 05, 2024
Via
Benzinga
Why Allurion Technologies Stock Is Racing Higher
April 04, 2024
Allurion Technologies' Virtual Care Suite (VCS) is now available to license in the United States for providers offering GLP-1 and other anti-obesity medication therapy, bariatric surgery, and weight...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
April 04, 2024
U.S. stocks turned lower toward the end of trading, with the Dow Jones index falling more than 200 points on Thursday. The Dow traded down 0.59% to 38,894.58 while the NASDAQ fell 0.10% to 16,261.88....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings
April 04, 2024
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 150 points on Thursday. The Dow traded up 0.49% to 39,319.03 while the NASDAQ rose 1% to 16,4340. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 04, 2024
Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3%...
Via
Benzinga
Dow Jumps Over 100 Points; US Jobless Claims Increase To 221,000
April 04, 2024
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.34% to 39,259.15 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Allurion Expands Virtual Care Suite to the United States
April 04, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
April 02, 2024
Via
Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
March 26, 2024
Via
Benzinga
ALUR Stock Earnings: Allurion Technologies Beats EPS, Beats Revenue for Q4 2023
March 21, 2024
ALUR stock results show that Allurion Technologies beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session
March 21, 2024
Via
Benzinga
Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
March 21, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Earnings Scheduled For March 21, 2024
March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
Via
Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
March 19, 2024
Via
Benzinga
Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
March 13, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair
March 12, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024
March 04, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On.
February 23, 2024
Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy.
Via
Investor's Business Daily
Allurion to Participate in Cowen’s 44th Annual Health Care Conference
February 20, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
February 08, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies
January 29, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
January 24, 2024
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.